Breaking News Instant updates and real-time market news.

TMUS

T-Mobile

$71.00

-2.8 (-3.79%)

, S

Sprint

$5.57

-0.31 (-5.27%)

09:04
04/17/19
04/17
09:04
04/17/19
09:04

Fly Intel: Pre-market Movers

HIGHER: Smart & Final Stores (SFS), up 20% after announcing that it has entered into a definitive merger agreement pursuant to which certain investment funds managed by affiliates of Apollo Global (APO) will acquire all the outstanding shares for $6.50 per share in cash... Hollysys (HOLI), up 10% after its 7.8M share secondary offering was canceled due to market conditions... Intel (INTC), up 4% after announcing its intention to exit the 5G smartphone modem business and complete an assessment of the opportunities for 4G and 5G modems in PCs, internet of things devices and other data-centric devices. UP AFTER EARNINGS: Pepsi (PEP), up 2%... Morgan Stanley (MS), up 2%. DOWN AFTER EARNINGS: BNY Mellon (BK), down 7%... PolyOne (POL), down 3%... IBM (IBM), down 2%. ALSO LOWER: T-Mobile (TMUS) and Sprint (S), down 3% and 7%, respectively, after a Wall Street Journal report suggested their merger is unlikely to be approved by the Department of Justice as currently structured. Sprint chairman Marcelo Claure has said the article is "not accurate" and T-Mobile CEO John Legere said via Twitter that the premise of the Journal story is "simply untrue."

TMUS

T-Mobile

$71.00

-2.8 (-3.79%)

S

Sprint

$5.57

-0.31 (-5.27%)

INTC

Intel

$56.40

0.13 (0.23%)

PEP

PepsiCo

$122.50

-1.14 (-0.92%)

MS

Morgan Stanley

$47.03

0.95 (2.06%)

SFS

Smart & Final Stores

$6.40

0.92 (16.79%)

HOLI

Hollysys

$18.90

0.09 (0.48%)

BK

BNY Mellon

$53.45

0.87 (1.65%)

POL

PolyOne

$30.87

0.405 (1.33%)

IBM

IBM

$141.00

-2.98 (-2.07%)

  • 17

    Apr

  • 17

    Apr

  • 17

    Apr

  • 17

    Apr

  • 25

    Apr

  • 30

    Apr

  • 01

    May

  • 01

    May

  • 08

    May

  • 16

    May

  • 16

    May

  • 18

    May

  • 10

    Jun

  • 11

    Jun

  • 11

    Jun

  • 17

    Apr

TMUS T-Mobile
$71.00

-2.8 (-3.79%)

04/15/19
04/15/19
DOWNGRADE
Target $196

Market Perform
American Tower downgraded to Market Perform on valuation at Wells Fargo
As previously reported, Wells Fargo analyst Jennifer Fritzsche downgraded American Tower (AMT) to Market Perform from Outperform, while raising her price target on the shares to $196 from $190. The analyst notes that the stock is up 25%-plus year to data. Furthermore, Fritzsche remains concerned about headwinds on the international side of its business as well as 2019 guidance, which likely will not fall into the normal "beat and raise" story it has seen in the past given somewhat of a holding pattern of spending by carriers in the U.S. Additionally, while the outcome of the looming Sprint (S)/T-Mobile (TMUS) merger could impact the group overall, American Tower's valuation could be more impacted given its strong performance year to date, she contends.
02/28/19
02/28/19
DOWNGRADE

Perform
American Tower downgraded to Perform on valuation at Oppenheimer
As previously reported, Oppenheimer analyst Timothy Horan downgraded American Tower (AMT) to Perform from Outperform on valuation. The analyst notes that the stock is up 19.5% since his wireless tower outlook published in early October, while Crown Castle (CCI) is up only 7.5%. While Horan acknowledges that American Tower's fundamentals are strong and the company is well positioned for growth, he believes there are near-term concerns. India churn brings volatility into the model, rising rates are a risk, as is the Spring (S)/T-Mobile (TMUS) merger and forex, he contends.
02/28/19
BTIG
02/28/19
NO CHANGE
Target $60
BTIG
Buy
SoftBank price target raised to $60 from $50 at BTIG
BTIG analyst Walter Piecyk raised his price target on SoftBank (SFTBY) to $60 and kept his Buy rating, citing his "better understanding" of the previously acquired ARM Holdings business which warrants a higher multiple. The analyst also sees a major catalyst coming in the "imminent decision" around Sprint (S) / T-Mobile (TMUS) deal, which could amount to additional $14 price target impact on Softbank shares.
02/12/19
KEYB
02/12/19
NO CHANGE
Target $195
KEYB
Overweight
SBA Communications price target raised to $195 from $183.97 at KeyBanc
KeyBanc analyst Brandon Nispel raised his price for SBA Communications (SBAC) to $195 from $183.97 and reiterated an Overweight rating on the shares. The analyst believes that if the T-Mobile (TMUS)/Sprint (S) merger goes through, 2020 should be another year of growth acceleration.
S Sprint
$5.57

-0.31 (-5.27%)

INTC Intel
$56.40

0.13 (0.23%)

04/10/19
DADA
04/10/19
NO CHANGE
Target $21
DADA
Buy
FormFactor price target raised to $21 from $18 at DA Davidson
DA Davidson analyst Thomas Diffely raised his price target on FormFactor (FORM) to $21 and kept his Buy rating after meeting with its management at an investor event last week. The analyst says investors were "pleasantly surprised" by the stability of the company's "design driven model" during industry slowdowns, adding that he sees FormFactor's "unique business drivers" being "larger then expected". Diffely further cites a potential revenue recovery at Intel (INTC), continued revenue growth at TSMC (TSM), and ramping activity from 5G and photonic" markets in concluding that FormFactor's growth prospects look "increasingly bullish".
04/17/19
KEYB
04/17/19
NO CHANGE
KEYB
Sector Weight
Intel 5G modem challenges a key factor leading to Apple settlement, says KeyBanc
KeyBanc analyst John Vinh notes that Qualcomm (QCOM) and Apple (AAPL) announced an agreement to dismiss all legal proceedings between the two companies worldwide, and says he believes challenges at Intel (INTC) on its 5G modem were a key factor leading to the settlement. The analyst also thinks this settlement likely will lead to a Huawei settlement, which could add another 80c in EPS for Qualcomm. While Vinh views the settlement as encouraging and as removing a major overhang for Qualcomm, he remains Sector Weight as he believes the economic benefit from the Apple settlement is largely reflected in the stock.
04/17/19
KEYB
04/17/19
NO CHANGE
KEYB
Intel's plans to exit 5G Modem business not impacting 2019 outlook, says KeyBanc
KeyBanc analyst Weston Twigg says that on the heels of the Apple (AAPL)/Qualcomm (QCOM) deal, Intel (INTC) announced that it plans to exit the 5G smartphone modem business, which was originally expected to ramp in 2020 but was likely running behind schedule. The analyst believes that continued investment in its low-margin modem business made "little strategic sense" amid fab capacity constraints. Twigg does not expect this to impact Intel's 2019 outlook, though it is possible that it could improve the company's longer-term revenue and margin profile.
04/17/19
FBCO
04/17/19
NO CHANGE
Target $58
FBCO
Outperform
Meaningful share loss for Intel in 2020 after Apple, Qualcomm settlement, says Credit Suisse
Credit Suisse analyst John Pitzer notes that Qualcomm (QCOM) and Apple (AAPL) reported that they have settled their royalty dispute, following a roughly two-year legal battle that began in early 2017 - and resulted in Intel (INTC) gaining about 50% share in new iPhone SKUs in 2017 and 100% share of new SKUs in 2018. While the analyst sees little risk to Intel's CY19 Apple Revenue as modem sockets are determined 9-12 months in advance, he sees the potential for meaningful share loss in 2020 especially in the second half of the year as Apple ramps 5G SKUs. Pitzer reiterates an Outperform rating and a $58 price target on Intel shares.
PEP PepsiCo
$122.50

-1.14 (-0.92%)

03/11/19
STFL
03/11/19
NO CHANGE
Target $67
STFL
Buy
Hypothetical Bang sale more negative than positive for Monster, says Stifel
Stifel analyst Mark Astrachan examined the hypothetical impact on Monster Beverage (MNST) should a larger beverages competitor acquire Bang, though he noted he has no knowledge of M&A negotiations or discussions with the energy drink competitor. He ultimately concluded a potential acquisition of Bang would be more negative than positive for Monster, though he also noted that risks of an acquisition include potential disruption of Bang's recent momentum, especially if it were to be acquired by PepsiCo (PEP) and transition distribution most likely in-house from the AB InBev (BUD) system. Additionally, a theoretical Bang deal could accelerate a decision by Coca-Cola (KO) regarding acquiring, or not, the remaining shares in Monster it does not currently own, said Astrachan, who keeps a Buy rating and $67 price target on Monster Beverage shares.
03/07/19
FBCO
03/07/19
INITIATION
FBCO
Credit Suisse starts Household Products & Beverages with Constellation top pick
Credit Suisse analyst Kaumil Gajrawala rolled out coverage last night on eight names in the Household Products & Beverages space. The analyst's ratings consist of three Outperforms, two Underperforms, and three Neutrals. His top pick is Constellation Brands (STZ), which he started with an Outperform rating and $230 price target. The company offers "predictable" high-single digit revenue growth with a valuation that is "well below slower growth peers," Gajrawala tells investors in a research note. His other Outperform ratings are on Monster Beverage (MNST) and Clorox (CLX). The analyst has a $78 price target on Monster, noting it is the fastest growing company in his coverage "with runway for continued growth." He has a $172 price target on Clorox saying the company's "unique" portfolio position justifies a premium valuation. Gajrawala's Neutral rated names are Church & Dwight (CHD), Procter & Gamble (PG) and Coca-Cola (KO). His two Underperforms are PepsiCo (PEP) and Colgate-Palmolive (CL). PepsiCo has a $100 price target as the analyst sees limited upside amid the company's "stepped-up" investment years. Colgate-Palmolive, Gajrawala's less favorite name, has a $55 price target. The company's out-year margins are at risk as it reinvests to address several years of slowing growth and sales declines, Gajrawala contends.
04/11/19
MSCO
04/11/19
DOWNGRADE
Target $24
MSCO
Underweight
Morgan Stanley downgrades Keurig Dr Pepper to Underweight on coffee risk
As previously reported, Morgan Stanley analyst Dara Mohsenian downgraded Keurig Dr Pepper to Underweight from Equal Weight as he sees a negative risk-reward despite a "well telegraphed" Q1 earnings beat on strong pricing at heritage Dr. Pepper Snapple. Based on the firm's recent AlphaWise survey, the analyst sees risk to coffee growth, noting that his forecast of around 1.5% is below the market-implied 4% long-term coffee topline growth, which is a key driver of his EPS forecast by 2021 being 5% below consensus. Additionally, Keurig Dr Pepper shares trade at a premium to the average of beverage peers Coca-Cola (KO) and PepsiCo (PEP) despite lower expected long-term topline growth, Mohsenian noted. He cut his price target on Keurig Dr Pepper shares to $24 from $27.
03/07/19
03/07/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Five Below (FIVE) initiated with an Outperform at Oppenheimer. 2. Teva (TEVA) reinstated with a Buy at UBS. 3. Chiasma (CHMA) initiated with an Overweight at Cantor Fitzgerald. 4. Monster Beverage (MNST) and Constellation Brands (STZ) were initiated with an Outperform at Credit Suisse, while Procter & Gamble (PG), Coca-Cola (KO), and Church & Dwight (CHD) were initiated with a Neutral, and PepsiCo (PEP), Colgate-Palmolive (CL), and Clorox (CLX) initiated with an Underperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
MS Morgan Stanley
$47.03

0.95 (2.06%)

04/16/19
BMOC
04/16/19
NO CHANGE
Target $260
BMOC
Market Perform
Goldman Sachs price target lowered to $260 from $262 at BMO Capital
BMO Capital analyst James Fotheringham lowered his price target on Goldman Sachs (GS) to $260 and kept his Market Perform rating after its Q1 results. The analyst says that in spite of the company's "broad-based beat", he is lowering his FY20 EPS view to $27.06 from $27.66 due to lower expected Investing and Lending net revenues along with higher credit provisions. Fotheringham prefers Morgan Stanley (MS) to Goldman Sachs since the two trade at a similar two-year-forward rolling earnings multiple, but the wealth management-oriented earnings mix of the former implies a premium that he expects to materialize.
02/01/19
02/01/19
DOWNGRADE

Sell
Societe Generale downgrades Goldman Sachs, Morgan Stanley to Sell
As previously reported, Societe Generale analyst Andrew Lim downgraded Goldman Sachs (GS) and Morgan Stanley (MS), both to Sell from Hold, citing his view that the credit cycle deterioration "has already been set in motion" and that it will pay to be defensive for the rest of 2019. Goldman and Morgan are much more exposed to pressure on market-sensitive revenues as purer investment banks, Lim tells investors. He does not have any Buy ratings on big U.S. banks, but continues to favor holding positions in Bank of America (BAC) and JP Morgan (JPM), which Lim views as the most defensive large cap U.S. banks, he tells investors.
02/01/19
SOCG
02/01/19
DOWNGRADE
SOCG
Sell
Morgan Stanley downgraded to Sell from Hold at Societe Generale
Societe Generale analyst Andrew Lim downgraded Morgan Stanley to Sell from Hold.
03/25/19
JEFF
03/25/19
NO CHANGE
JEFF
Jefferies downgrades Financials to Underweight on 'shocking' Fed meeting
Jefferies analyst Steven DeSanctis is "very surprised" by last week's Federal Reserve's decision taking rate hikes completely off table in 2019. The "shocking" Fed meeting means lower rates for longer, which is not good for Financials, DeSanctis tells investors in a research note. A "lack of catalysts and weaker earnings growth" going forward for the entire sector, not just banks, means an Underweight rating on the space makes sense, says the analyst. As such, he downgraded his rating on the Financial sector to Underweight from Market Weight. Publicly traded companies in the space include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).
SFS Smart & Final Stores
$6.40

0.92 (16.79%)

02/07/19
BUCK
02/07/19
INITIATION
BUCK
Neutral
Smart & Final Stores initiated with a Neutral at Buckingham
02/07/19
BUCK
02/07/19
INITIATION
Target $6.75
BUCK
Neutral
Smart & Final Stores initiated with a Neutral at Buckingham
Buckingham analyst Bob Summers started Smart & Final Stores with a Neutral rating and $6.75 price target. The analyst is concerned "pressure points" from competitive activity and cannibalization will persist and he does not view the current valuation as "overly accommodating."
04/17/19
WELS
04/17/19
DOWNGRADE
WELS
Market Perform
Smart & Final Stores downgraded to Market Perform from Outperform at Wells Fargo
04/17/19
OPCO
04/17/19
NO CHANGE
OPCO
Oppenheimer moving to Not Rated on Smart & Final Stores
Oppenheimer analyst Rupesh Parikh is moving to Not Rated from Perform on Smart & Final Stores (SFS), after the company agreed to be acquired by private equity firm Apollo Global Management (APO) for $6.50 a share.
HOLI Hollysys
$18.90

0.09 (0.48%)

04/09/19
JPMS
04/09/19
DOWNGRADE
Target $23
JPMS
Neutral
Hollysys downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Karen Li downgraded Hollysys Automation Technologies to Neutral from Overweight and lowered her price target for the shares to $23 from $26. The analyst views the company's 7.8M share offering as surprising.
08/16/18
MSCO
08/16/18
NO CHANGE
MSCO
Hollysys named a long Research Tactical Idea at Morgan Stanley
11/14/18
JPMS
11/14/18
UPGRADE
Target $24
JPMS
Overweight
Hollysys upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Karen Li upgraded n Hollysys Automation Technologies to Overweight while lowering her price target for the shares to $24 from $26 following last night's Q3 results. The company's rail segment outlook is improving while industrial automation demand is more resilient relative to peers, Li tells investors in a post-earnings research note. The analyst sees Hollysys' order flow in its rail transportation segment improving over the next 24 months.
04/17/19
JPMS
04/17/19
UPGRADE
JPMS
Overweight
Hollysys upgraded to Overweight from Neutral at JPMorgan
BK BNY Mellon
$53.45

0.87 (1.65%)

01/09/19
SBSH
01/09/19
DOWNGRADE
Target $52
SBSH
Neutral
BNY Mellon downgraded to Neutral from Buy at Citi
Citi analyst Keith Horowitz downgraded BNY Mellon to Neutral with a $52 price target. The analyst believes the company's valuation relative to peers has gotten full and says he cannot justify a strong case for 15% plus upside from current levels. He views BK as fairly valued at current prices.
01/08/19
JEFF
01/08/19
DOWNGRADE
Target $91
JEFF
Hold
Jefferies cuts trust bank estimates, downgrades Northern Trust to Hold
Jefferies analyst Ken Usdin downgraded Northern Trust (NTRS) to Hold from Buy and lowered his price target for the shares to $91 from $121. The sharp Q4 decline in market levels weighs on trust banks' revenue estimates, Usdin tells investors in a research note. He downgraded Northern Trust with his 2020 earnings estimate now 7% below consensus. Trust bank valuations remain below historical averages, but slower organic growth and "less macro help" are challenges, says the analyst. He also lowered his price target for Hold-rated BNY Mellon (BK) to $50 and Hold-rated State Street (STT) to $70.
10/19/18
10/19/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Las Vegas Sands (LVS) downgraded to Buy from Conviction Buy at Goldman Sachs. 2. eBay (EBAY) downgraded to Hold from Buy at Stifel with analyst Scott Devitt saying PayPal's (PYPL) earnings release last night suggested weak eBay gross merchandise volume trends in Q3. 3. Ford (F) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Adam Jonas saying he now believes the market needs more evidence of success before embracing the Ford restructuring story. 4. BNY Mellon (BK) downgraded to Underperform from Market Perform at Keefe Bruyette with analyst Brian Kleinhanzl saying while the company beat estimates this quarter, several line items were weaker than expectations. 5. Harley-Davidson (HOG) downgraded to Market Perform from Outperform at BMO Capital with analyst Gerrick Johnson saying his previously expected catalysts for sales and earnings did not materialize. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/19/18
KBWI
10/19/18
DOWNGRADE
Target $49
KBWI
Underperform
BNY Mellon downgraded to Underperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl downgraded BNY Mellon to Underperform and lowered his price target for the shares to $49 from $55. While the company beat estimates this quarter, several line items were weaker than expectations, Kleinhanzl tells investors in a research note. He cut his 2019 and 2020 estimates again as a result of limited upside and limited visibility into BNY Mellon's earnings power.
POL PolyOne
$30.87

0.405 (1.33%)

01/24/19
BARD
01/24/19
NO CHANGE
Target $32
BARD
Neutral
PolyOne elevated to Fresh Pick at Baird
Baird analyst Ben Kallo elevated PolyOne to Fresh Pick ahead of its Q4 report. The analyst believes the company could be less exposed to China than some peers and he thinks management could surpass lowered expectations. Kallo said he would be buyer ahead of the earnings report and he maintained his Neutral rating and $32 price target on PolyOne shares.
02/06/19
BUCK
02/06/19
INITIATION
Target $40
BUCK
Buy
PolyOne initiated with a Buy at Buckingham
Buckingham analyst Dimitry Silversteyn initiated PolyOne with a Buy and $40 price target citing ongoing price/mix improvements offsetting slower volume growth, and the potential for lower input costs in 2H 2019.
02/06/19
02/06/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Nasdaq (NDAQ) initiated with a Buy at Argus. 2. Marinus Pharmaceuticals (MRNS) initiated with an Outperform at Leerink. 3. PolyOne (POL) initiated with a Buy at Buckingham. 4. Marathon Petroleum (MPC) initiated with an Outperform at Macquarie. 5. CymaBay (CBAY) initiated with a Neutral at B. Riley FBR.This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/05/19
BUCK
02/05/19
INITIATION
BUCK
Buy
PolyOne initiated with a Buy at Buckingham
IBM IBM
$141.00

-2.98 (-2.07%)

03/15/19
BMOC
03/15/19
DOWNGRADE
Target $53
BMOC
Market Perform
Oracle downgraded to Market Perform from Outperform at BMO Capital
BMO Capital analyst Keith Bachman downgraded Oracle (ORCL) to Market Perform from Outperform with an unchanged price target of $53 following last night's fiscal Q3 results. The stock in premarket trading is down 3%, or $1.65, to $51.40. The analyst believes Oracle can sustain ~2% constant currency revenue growth, but is "dubious" the company can improve its revenue growth rates. He does not think autonomous database or gradual unfolding of the cloud enterprise resource planning market will help Oracle's growth in fiscal 2020. As demonstrated by IBM (IBM) over the years, an aggressive buyback will not be enough to push the shares meaningfully higher without improved top-line results, Bachman tells investors in a post-earnings research note. As such, he sees a balanced risk/reward profile at current share levels.
03/26/19
BERN
03/26/19
NO CHANGE
BERN
Red Hat worth $190/share 'even as stand alone entity,' says Bernstein
Bernstein analyst Zane Chrane notes that Red Hat's (RHT) Q4 results are unlikely to have a material impact on the stock price given the expected acquisition by IBM (IBM) in the second half of 2019. However, strong growth in emerging products, continued reacceleration in RHEL revenue, and robust growth in deferred revenue and backlog all suggest the company is having increasing success in cross-selling its hybrid cloud solutions to large enterprise customers, he contends, adding that this quarter's results were "strong across the board," suggesting that the pending IBM deal is not having any negative impact on the company's execution. Chrane believes Red Hat is worth $190 per share "even as a stand-alone entity."
04/11/19
FBCO
04/11/19
INITIATION
Target $173
FBCO
Outperform
IBM initiated with an Outperform at Credit Suisse
Credit Suisse analyst Matt Cabral initiated IBM (IBM) with an Outperform rating and a price target of $173. The analyst cites the impact of the company's pending Red Hat (RHT) acquisition generating synergies while bringing together the industry expertise and incumbency to "help customers move to hybrid". Cabral adds that while IBM has sustainable free cash flow of about $12B ex-Red Hat, he expects the deal to be cash flow accretive in the first year, becoming the company's "main driver of growth".
04/17/19
SBSH
04/17/19
NO CHANGE
Target $140
SBSH
Neutral
IBM price target raised to $140 from $130 at Citi
Citi analyst Jim Suva raised his price target for IBM to $140 from $130 and maintains a Neutral rating on the shares following the company's Q1 results. The report "can best be described as something for everyone to debate with several positives and negatives," Suva tells investors in a research note. He believes the earnings were not enough to get investors to change their view to either a more positive or more negative view.

TODAY'S FREE FLY STORIES

HESM

Hess Midstream Partners

$22.89

0.09 (0.39%)

08:00
04/25/19
04/25
08:00
04/25/19
08:00
Hot Stocks
Hess Midstream Partners plans to expand natural gas processing capacity »

Hess Midstream Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

HAS

Hasbro

$103.18

2.84 (2.83%)

08:00
04/25/19
04/25
08:00
04/25/19
08:00
Downgrade
Hasbro rating change  »

Hasbro downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 29

    May

08:00
04/25/19
04/25
08:00
04/25/19
08:00
General news
U.S. initial jobless claims preview: »

U.S. initial jobless…

NMCI

Navios Maritime Containers

$2.24

(0.00%)

07:58
04/25/19
04/25
07:58
04/25/19
07:58
Hot Stocks
Navios Maritime Containers announces delivery of one containership »

Navios Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LRCX

Lam Research

$195.40

0.56 (0.29%)

07:56
04/25/19
04/25
07:56
04/25/19
07:56
Recommendations
Lam Research analyst commentary at Citi »

Citi ups target on top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

TSLA

Tesla

$258.70

-5.15 (-1.95%)

07:55
04/25/19
04/25
07:55
04/25/19
07:55
Downgrade
Tesla rating change  »

Tesla downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$125.00

-0.5 (-0.40%)

07:55
04/25/19
04/25
07:55
04/25/19
07:55
Recommendations
Microsoft analyst commentary at BMO Capital »

Microsoft price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 23

    Jun

  • 06

    Aug

VBIV

VBI Vaccines

$2.00

(0.00%)

07:55
04/25/19
04/25
07:55
04/25/19
07:55
Conference/Events
VBI Vaccines to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

  • 23

    May

UBSI

United Bankshares

$38.81

0.03 (0.08%)

07:53
04/25/19
04/25
07:53
04/25/19
07:53
Earnings
United Bankshares reports Q1 EPS 62c, consensus 61c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 15

    May

HBAN

Huntington Bancshares

$13.75

-0.04 (-0.29%)

07:53
04/25/19
04/25
07:53
04/25/19
07:53
Hot Stocks
Huntington Bancshares reaffirms three-year target of 4%-6% revenue growth »

For 2019, sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

  • 31

    May

  • 29

    Aug

APC

Anadarko

$71.41

7.29 (11.37%)

, OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

07:52
04/25/19
04/25
07:52
04/25/19
07:52
Downgrade
Anadarko, Occidental Petroleum, Chevron rating change at Jefferies »

Jefferies downgrades…

APC

Anadarko

$71.41

7.29 (11.37%)

OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

CVX

Chevron

$118.31

-3.69 (-3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 28

    Apr

  • 30

    Apr

  • 07

    May

  • 10

    May

  • 14

    May

  • 22

    May

  • 29

    May

MTSI

Macom

$15.86

-0.33 (-2.04%)

07:51
04/25/19
04/25
07:51
04/25/19
07:51
Downgrade
Macom rating change  »

Macom downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:49
04/25/19
04/25
07:49
04/25/19
07:49
Hot Stocks
AbbVie reports Q1 global hematologic oncology portfolio revenue $1.173B »

Global net revenues from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

APC

Anadarko

$71.41

7.29 (11.37%)

, OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

07:48
04/25/19
04/25
07:48
04/25/19
07:48
Recommendations
Anadarko, Occidental Petroleum, Chevron analyst commentary at Morgan Stanley »

Strategic value of…

APC

Anadarko

$71.41

7.29 (11.37%)

OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

CVX

Chevron

$118.31

-3.69 (-3.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 28

    Apr

  • 30

    Apr

  • 07

    May

  • 10

    May

  • 14

    May

  • 22

    May

  • 29

    May

PTC

PTC

$101.94

1.12 (1.11%)

07:48
04/25/19
04/25
07:48
04/25/19
07:48
Downgrade
PTC rating change  »

PTC downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXGN

NextGen Healthcare

$17.65

0.38 (2.20%)

07:47
04/25/19
04/25
07:47
04/25/19
07:47
Upgrade
NextGen Healthcare rating change  »

NextGen Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:47
04/25/19
04/25
07:47
04/25/19
07:47
Hot Stocks
AbbVie CEO says 'we are off to another excellent start' »

"We are off to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:46
04/25/19
04/25
07:46
04/25/19
07:46
Hot Stocks
AbbVie reports Q1 U.S. HUMIRA sales of $3.215B up 7.1% »

IInternationally, HUMIRA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

AZPN

Aspen Technology

$114.55

2.435 (2.17%)

07:45
04/25/19
04/25
07:45
04/25/19
07:45
Upgrade
Aspen Technology rating change  »

Aspen Technology upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

07:45
04/25/19
04/25
07:45
04/25/19
07:45
General news
Treasury Market Outlook: bond markets are mixed »

Treasury Market Outlook:…

XLNX

Xilinx

$139.79

2.66 (1.94%)

07:44
04/25/19
04/25
07:44
04/25/19
07:44
Downgrade
Xilinx rating change at Needham »

Xilinx downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

CIGI

Colliers International

$69.14

-0.39 (-0.56%)

07:44
04/25/19
04/25
07:44
04/25/19
07:44
Hot Stocks
Colliers International acquires affiliate in Sweden »

Colliers International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:43
04/25/19
04/25
07:43
04/25/19
07:43
Earnings
AbbVie raises FY19 adj. EPS view to $8.73-$8.83 from $8.65-$8.75 »

FY19 consensus $8.69. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

HAS

Hasbro

$103.18

2.84 (2.83%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Downgrade
Hasbro rating change at Argus »

Hasbro downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 29

    May

WAB

Wabtec

$76.57

-0.19 (-0.25%)

, GE

General Electric

$9.32

-0.025 (-0.27%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Hot Stocks
Wabtec CEO Ray Betler to retire, Rafael Santana to succeed »

Wabtec (WAB) announced…

WAB

Wabtec

$76.57

-0.19 (-0.25%)

GE

General Electric

$9.32

-0.025 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 08

    May

  • 08

    May

  • 21

    May

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.